SSA
HZNP

Schonfeld Strategic Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-538,836
Closed -$62.3M – 2371
2023
Q3 		$62.3M Buy
538,836
+371,452
+222% +$39.9M 0.48% 24
2023
Q2 		$17.2M Buy
167,384
+142,842
+582% +$15.1M 0.15% 212
2023
Q1 		$2.68M Sell
24,542
-127,990
-84% -$14.1M 0.03% 610
2022
Q4 		$17.4M Sell
152,532
-7,811
-5% -$649K 0.14% 205
2022
Q3 		$9.92M Buy
160,343
+44,422
+38% +$3.1M 0.08% 310
2022
Q2 		$9.24M Buy
115,921
+57,881
+100% +$5.48M 0.09% 292
2022
Q1 		$6.11M Buy
58,040
+36,840
+174% +$3.59M 0.06% 387
2021
Q4 		$2.28M Sell
21,200
-47,909
-69% -$5.23M 0.02% 669
2021
Q3 		$7.57M Buy
69,109
+16,392
+31% +$1.7M 0.08% 325
2021
Q2 		$4.94M Buy
52,717
+11,154
+27% +$1.03M 0.05% 467
2021
Q1 		$3.83M Buy
41,563
+18,263
+78% +$1.54M 0.05% 501
2020
Q4 		$1.7M Sell
23,300
-109,175
-82% -$8.12M 0.02% 644
2020
Q3 		$10.3M Buy
132,475
+87,663
+196% +$6.03M 0.2% 140
2020
Q2 		$2.49M Buy
44,812
+17,845
+66% +$763K 0.06% 349
2020
Q1 		$799K Sell
26,967
-18,442
-41% -$624K 0.05% 435
2019
Q4 		$1.65M Sell
45,409
-186,573
-80% -$5.72M 0.04% 375
2019
Q3 		$6.32M Buy
231,982
+159,443
+220% +$4.12M 0.19% 142
2019
Q2 		$1.75M Buy
+72,539
New +$1.84M 0.06% 317
2017
Q1 		– Sell
-20,000
Closed -$324K – 809
2016
Q4 		$324K Sell
20,000
-13,109
-40% -$238K 0.04% 411
2016
Q3 		$600K Buy
33,109
+21,636
+189% +$423K 0.1% 248
2016
Q2 		$189K Sell
11,473
-65,902
-85% -$1.07M 0.04% 382
2016
Q1 		$1.28M Buy
+77,375
New +$1.35M 0.52% 48

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's HZNP Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 538,836 shares — an estimated $62.3M sold.

Schonfeld Strategic Advisors first reported a position in HZNP in Q1 2016 and held it in 22 quarters. The position peaked at $62.3M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 538,836 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $62.3M.
  • Schonfeld Strategic Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 22 quarters.
  • Schonfeld Strategic Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $62.3M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.